Terms: = Germ cell tumor AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967 AND Treatment
5 results:
1. Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutation.
Garrisi VM; Strippoli S; De Summa S; Pinto R; Perrone A; Guida G; Azzariti A; Guida M; Tommasi S
PLoS One; 2014; 9(12):e112025. PubMed ID: 25437182
[TBL] [Abstract] [Full Text] [Related]
2. Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma.
Vu HL; Aplin AE
Mol Cancer Res; 2014 Oct; 12(10):1509-19. PubMed ID: 24962318
[TBL] [Abstract] [Full Text] [Related]
3. Early thyroid hormone-induced gene expression changes in N2a-β neuroblastoma cells.
Bedó G; Pascual A; Aranda A
J Mol Neurosci; 2011 Oct; 45(2):76-86. PubMed ID: 20506002
[TBL] [Abstract] [Full Text] [Related]
4. Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.
Errington F; White CL; Twigger KR; Rose A; Scott K; Steele L; Ilett LJ; Prestwich R; Pandha HS; Coffey M; Selby P; Vile R; Harrington KJ; Melcher AA
Gene Ther; 2008 Sep; 15(18):1257-70. PubMed ID: 18401435
[TBL] [Abstract] [Full Text] [Related]
5. [A histological technique for processing excised skin tumors for continuous tumor margin control].
Holzschuh J; Breuninger H
Pathologe; 1996 Mar; 17(2):127-9. PubMed ID: 8650140
[TBL] [Abstract] [Full Text] [Related]
